MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-06-2025
Smith & Nephew plc DPO Ratio 2011-2025 | SNN
Annual DPO Ratio Smith & Nephew plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 232 | 258 | 253 | 249 | 220 | 181 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 258 | 181 | 232 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
76.2 | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.6 | - | $ 125 M | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 96.13 | 0.04 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 301.75 | 0.24 % | $ 8.51 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 48.12 | 0.21 % | $ 7.17 K | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 124.81 | 0.22 % | $ 217 B | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 2.97 | 4.58 % | $ 111 M |  France |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
InMode Ltd.
INMD
|
65.1 | $ 14.47 | 0.7 % | $ 1.15 B |  Israel |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 9.54 | - | $ 685 M | Israel |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 157.84 | 0.69 % | $ 11.8 B | USA |
 |
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.86 | 0.43 % | $ 88.4 M | USA |
 |
Myomo
MYO
|
44.5 | $ 1.02 | 12.09 % | $ 7.19 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 14.49 | 0.84 % | $ 392 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 14.53 | 0.07 % | $ 95.2 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.14 | 3.64 % | $ 18.4 M | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 97.06 | 0.48 % | $ 1.23 B | USA |
 |
AxoGen
AXGN
|
79.6 | $ 32.64 | -0.61 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 40.17 | 1.34 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
70.1 | $ 17.41 | 0.75 % | $ 402 M | USA |
 |
Globus Medical
GMED
|
23.2 | $ 88.43 | -0.38 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 12.66 | 0.56 % | $ 975 M | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
LivaNova PLC
LIVN
|
71.8 | $ 63.08 | -0.27 % | $ 3.42 B |  Britain |
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.49 | -6.39 % | $ 3.89 M | USA |
|
LENSAR
LNSR
|
66 | $ 12.01 | -0.08 % | $ 138 M | USA |